Zhan, Yang <br/><br/>
Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancer.  [electronic resource] 

 -  International journal of cancer  Nov 2013 
 - 2225-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.28202  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgen Antagonists--pharmacology<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Benzamides<br/>Cell Line, Tumor<br/>Chromatography, Thin Layer<br/>DNA, Neoplasm--genetics<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Male<br/>Methanol--analogs & derivatives<br/>Mice<br/>Mice, Nude<br/>Nitriles<br/>Orchiectomy<br/>Organoselenium Compounds--pharmacology<br/>Phenylthiohydantoin--analogs & derivatives<br/>Polymerase Chain Reaction<br/>Prostatic Neoplasms--drug therapy<br/>Receptors, Androgen--genetics<br/>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization